Clinical Trials on Type II Diabetes Control in Sweden
Total 422 results
-
Vastra Gotaland RegionGöteborg UniversityRecruiting
-
Imcyse SACompletedType 1 Diabetes MellitusUnited Kingdom, Belgium, France, Lithuania, Denmark, Germany, Sweden
-
Vastra Gotaland RegionDexCom, Inc.CompletedDiabetes Mellitus, Type 1Sweden
-
Karolinska InstitutetRecruitingDiabetes Mellitus, Type 2 | Pediatric Obesity | Prediabetic State | Overweight, Childhood | Overnutrition, ChildSweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, United Kingdom, Sweden, Finland
-
Diamyd Medical ABCompletedGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic Disease | Vitamin D | Autoimmune Diabetes | Physiological Effects of Drugs | Juvenile Diabetes | Insulin Dependent DiabetesCzechia, Netherlands, Spain, Sweden
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
Dr Christopher MarguerieInstitut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsUnknownDepression | Heart Failure | Renal Failure | Chronic Disease | Aging | Diabetes Type 2Spain, Sweden, United Kingdom
-
Karolinska InstitutetUppsala University HospitalCompletedDiabetes Mellitus Typ 2 and ObesitySweden
-
National Institute of Diabetes and Digestive and...Juvenile Diabetes Research FoundationTerminatedType1 Diabetes MellitusUnited States, Australia, Italy, United Kingdom, Sweden, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Israel, Korea, Republic of, Turkey, Italy, Belgium, United Kingdom, Greece, Ireland, Sweden, Denmark, Finland, France, Czech Republic
-
Genzyme, a Sanofi CompanyCompletedFamilial HypercholesterolemiaNetherlands, France, Germany, Sweden, United Kingdom
-
Karolinska InstitutetThe Swedish Research Council; Region StockholmCompletedObesity | Type 2 Diabetes | Insulin SensitivitySweden
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
-
Karolinska University HospitalKarolinska InstitutetCompletedAtherosclerosis | Type2 DiabetesSweden
-
Helmholtz Zentrum MünchenUniversitaire Ziekenhuizen KU Leuven; Technical University of Munich; Medical... and other collaboratorsRecruitingDiabetes Mellitus, Type 1Belgium, Germany, Poland, Sweden, United Kingdom
-
SanofiRecruitingType 1 Diabetes MellitusBelgium, Spain, Canada, United States, Poland, France, Sweden, Denmark, Germany, Italy, United Kingdom, Hungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Sweden, Denmark
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark, Sweden, United Kingdom, Norway
-
Northwestern UniversityGlaxoSmithKline; National Comprehensive Cancer NetworkActive, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Sweden
-
Assistance Publique - Hôpitaux de ParisIltoo PharmaCompletedType 1 DiabetesBelgium, France, Germany, Netherlands, Sweden, Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
Diamyd Medical ABRecruitingType 1 Diabetes MellitusCzechia, Spain, United States, Hungary, Netherlands, Estonia, Germany, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Denmark, Croatia, Australia, South Africa, Italy, Sweden
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
TakedaCompleted
-
Diamyd Therapeutics ABTerminatedType 1 Diabetes MellitusFrance, Germany, Finland, Italy, Netherlands, Slovenia, Spain, Sweden, United Kingdom
-
Novo Nordisk A/SEnrolling by invitationDiabetes Mellitus, Type 1Belgium, France, Denmark, Sweden
-
AstraZenecaOptum, Inc.Completed
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Medtronic DiabetesRecruitingType 1 DiabetesUnited States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Imcyse SATerminatedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Lithuania, Belgium, Italy, Slovenia, Sweden
-
SanofiCompletedDiabetes Mellitus, Type 1Belgium, France, Netherlands, Sweden
-
Hoffmann-La RocheCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Germany, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark, Sweden, Norway
-
SanofiCompletedDiabetes Mellitus, Type 2France, Spain, Italy, Belgium, Germany, Poland, Portugal, Czech Republic, Slovakia, Australia, Netherlands, Sweden, United Kingdom, Switzerland, Romania
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Italy, Spain, Sweden, Canada, Bulgaria, Poland, Czechia
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
-
Peter SiesjöLund University; Region Skåne; Skane University Hospital; Lantmannen Medical ABCompletedGlioblastoma | Chemotherapy Effect | Cerebral EdemaSweden
-
ITB-Med LLCRecruitingDiabetes Mellitus, Type 1Belgium, Spain, United Kingdom, Italy, Germany, Poland, France, Sweden
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece